Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_assertion type Assertion NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_head.
- NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_assertion description "[Moreover, as few as 1,000 CD133(+) MRTK cells initiated tumor development in nonobese diabetic/severe combined immunodeficient mice by 21 days (60-100%) in all examined cell lines, although the same number of CD133(-) MRTK cells could not form tumors (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_provenance.
- NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_assertion evidence source_evidence_literature NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_provenance.
- NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_assertion SIO_000772 19383826 NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_provenance.
- NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_assertion wasDerivedFrom befree-20140225 NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_provenance.
- NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_assertion wasGeneratedBy ECO_0000203 NP384000.RA2so0ARUdAu4iEhzUuojgUmB4awedYVgwlILys07sRvk130_provenance.